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Early events in vaccinia virus (VAC) morphogenesis, particularly the formation of viral membranes and their association with viroplasm,
are poorly understood. Recently, we showed that repression of A30 or G7 expression results in the accumulation of normal viral membranes
that form empty-looking immature virions (IV), which are separated from large masses of electron-dense viroplasm. In addition, A30 and G7
physically and functionally interact with each other and with the F10 protein kinase. To identify other proteins involved in early
morphogenesis, proteins from cells that had been infected with vaccinia virus expressing an epitope-tagged copy of F10 were purified by
immunoaffinity chromatography and analyzed by gel electrophoresis. In addition to F10, A30, and G7, viral proteins A15, D2, D3, and J1
were identified by mass spectrometry of tryptic peptides. Further evidence for the complex was obtained by immunopurification of proteins
associated with epitope-tagged A15, D2, and D3. The previously unstudied A15, like other proteins in the complex, was expressed late in
infection, associated with virus cores, and required for the stability and kinase activity of F10. Biochemical and electron microscopic analyses
indicated that mutants in which A15 or D2 expression was regulated by the Escherichia coli lac operator system exhibited phenotypes
characterized by the presence of large numbers of empty immature virions, similar to the results obtained with inducible A30 and G7 mutants.
Empty immature virions were also seen by electron microscopy of cells infected with temperature-sensitive mutants of D2 or D3, though the
numbers of membrane forms were reduced perhaps due to additional effects of high temperature.
Published by Elsevier Inc.
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Vaccinia virus (VAC) morphogenesis occurs in the
cytoplasm of infected cells through a series of intermediate
structures that have been visualized by electron microscopy
(Dales and Siminovitch, 1961; Grimley et al., 1970; Risco
et al., 2002). Crescent-shaped membranes with electron-
dense granular material (viroplasm) adjacent to the concave0042-6822/$ - see front matter. Published by Elsevier Inc.
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E-mail address: bmoss@nih.gov (B. Moss).side evolve into spherical, immature virions (IV), which
enclose a nucleoprotein mass. Further maturational events,
including proteolytic processing of viral core proteins
(Ansarah-Sobrinho and Moss, 2004; Byrd et al., 2003; Moss
and Rosenblum, 1973) and intramolecular disulfide bonding
of viral membrane proteins (Senkevich et al., 2002), result in
the transformation of IV into infectious brick-shaped intra-
cellular mature virions (IMVs). Some IMVs are wrapped by
cisternae, derived from the trans-Golgi network or early
endosomes (Hiller and Weber, 1985; Schmelz et al., 1994;
Tooze et al., 1993) to form intracellular enveloped virions
(IEVs). The IEVs, which contain two additional membranes
relative to IMV, bind to microtubules and are transported to
the periphery of the cell (Geada et al., 2001; Hollinshead04) 447–459
P. Szajner et al. / Virology 330 (2004) 447–459448et al., 2001; Rietdorf et al., 2001; Ward and Moss, 2001a,
2001b; Ward and Moss, 2004), where the outermost
membrane fuses with the plasma membrane, depositing
cell-associated enveloped virions (CEVs) on the cell surface
(Blasco and Moss, 1992). Actin polymerizes at the site of
membrane fusion resulting in the formation of microvilli
with CEV at their tips, thereby facilitating virus spread
(Hollinshead et al., 2001; Rietdorf et al., 2001; Stokes, 1976;
Ward and Moss, 2001a). Some extracellular enveloped
virions (EEVs) are released into the medium and promote
spread to distant cells (Appleyard et al., 1971; Blasco et al.,
1993; Boulter and Appleyard, 1973; Payne, 1980).
Early events in VAC morphogenesis, particularly the
formation of viral membranes and their association with the
viroplasm, are poorly understood. Recently, we showed that
the viral A30 and G7 proteins are components of the virus
core and that repression of either gene results in the
accumulation of normal-looking viral membranes forming
empty-looking IVs that are separated from large masses of
viroplasm (Szajner et al., 2001b, 2003). A30 and G7 interact
with each other, and this association is necessary for the
stability of each protein. In addition, when either A30 or G7
is repressed, phosphorylation of the A17 membrane protein
by the F10 kinase is severely reduced (Szajner et al., 2004b).
This observation led us to find a physical interaction of A30
and G7 with F10 (Szajner et al., 2004b). Just as A30 and G7
are mutually dependent on each other for stability, F10 is
nearly undetectable in the absence of A30 and G7.
Furthermore, phosphorylation of A30 is dependent on the
F10 kinase and autophosphorylation of F10 is stimulated by
A30 and G7. F10 is also required for viral membrane
formation (Traktman et al., 1995; Wang and Shuman, 1995)
and the catalytic site is required for this function but not for
the physical interaction with A30 and G7 (Szajner et al.,
2004a, 2004b). Thus, F10 may have distinct roles in the
formation of the viral membrane and the association of the
membrane with viroplasm.
Using epitope tagging, immunoaffinity purification, and
mass spectrometry, we now show that A15, D2, D3, and J1
are components of the complex containing A30, G7, and
F10. Previously isolated viruses with conditionally lethal
mutations of J1 (Chiu and Chang, 2002), D2 (Dyster and
Niles, 1991), and D3 (Dyster and Niles, 1991) have been
directly or indirectly shown to have blocks in morpho-
genesis. Our present study, which includes the initial
characterization of A15 and a further characterization of
D2 and D3, demonstrates that these proteins are also
required for the association of membranes and viroplasm.Fig. 1. Identification by mass spectrometry of viral proteins that associate
with affinity purified F10V5. BS-C-1 cells were infected with vF10V5 or
VAC strain WR for 48 h. The cells were lysed and clarified cell lysates were
incubated with anti-V5 MAb conjugated to beads. After washing, proteins
bound to the beads were eluted, resolved by SDS-PAGE, and stained with
Coomassie blue. The positions and masses of marker proteins are shown on
the left. The bands indicated on the right were excised and the proteins were
identified by liquid chromatography and mass spectroscopy of tryptic
peptides.Results
Identification of a complex containing seven VAC proteins
In previous studies we provided evidence for a complex
containing A30, G7, and F10 proteins (Szajner et al., 2003,2004b). Sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) of metabolically labeled proteins,
however, suggested that additional polypeptides co-immu-
noprecipitated with F10. To identify additional interacting
proteins, extracts from cells infected with vF10V5 (pre-
viously called vWT-F10V5), a recombinant VAC that
contains a V5 epitope-tagged copy of F10 (Szajner et al.,
2004b), were incubated with an anti-V5 monoclonal anti-
body (MAb) covalently linked to beads. After washing, the
bound proteins were eluted, resolved by SDS-PAGE, and
visualized by Coomassie blue staining. As a control,
extracts from cells infected with wild-type VAC were
analyzed in parallel. By comparison of the bands in the
two lanes, we could discriminate between proteins that
bound nonspecifically to the beads from those that were
associated with F10V5. Five distinct bands unique to the
sample from cells infected with F10V5 were detected (Fig.
1). These bands were excised, digested with trypsin, and
analyzed by liquid chromatography and mass spectrometry.
Bands of about 50, 42, and 9 kDa contained peptides with
masses corresponding to predicted ones from the F10, G7,
and A30 proteins, respectively. Additional tryptic peptides
from the bands indicated in Fig. 1 were identified as
digestion products of A15, D2, D3, and J1.
The proteins that co-purified with F10V5 could represent
individual proteins bound to F10, multiple small complexes,
or a single large complex. The existence of complexes was
previously shown by co-purification of F10, A30, and G7
when antibodies to epitope-tagged F10 or A30 were used
(Szajner et al., 2004b). To extend the analysis, we made the
recombinant virus vA15V5, in which a V5 epitope tag was
appended to the predicted C-terminus of the A15L open
reading frame (ORF) without disturbing its natural pro-
moter. To facilitate isolation of the recombinant virus, the
ORF for enhanced green fluorescent protein (GFP) regu-
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A15L and A14L ORFs with the deletion of the non-essential
A14.5 gene (Betakova et al., 2000). Cells were infected with
vA15V5 and the proteins present in the total lysate or the
ones affinity purified with anti-V5 MAb were analyzed by
Western blotting with antibodies specific for F10, G7, J1,
V5, and A30. Strips excised from the Western blots are
shown in Fig. 2A. The bands detected in the total lysates of
cells infected with the control virus (vT7lacOI) or vA15V5
were identical, except for the expected absence of the
epitope-tagged A15V5 in the former. Each of the proteinsFig. 2. Identification of viral protein components of the complex by
Western blotting. (A) Western blots of proteins that co-purified with
A15V5. BS-C-1 cells were infected for 24 h with vA15V5 or control virus
vT7lacOI and the clarified lysates were incubated with beads containing
covalently bound anti-V5 MAb and then washed extensively. The lysate
and the proteins bound to the V5 MAb were analyzed by SDS-PAGE,
transferred to a nylon membrane, and probed with antibodies to F10, G7,
J1, V5, and A30. (B) Western blots of proteins that co-purified with D2Fl.
Similar to panel A except that cells were infected with vD2Fl or the parental
vF10V5 and the proteins were purified by binding to beads containing
covalently bound anti-Flag MAb. (C and D) Western blotting following co-
transfections. Cells were infected with vT7lacOI and transfected with
combinations of plasmids expressing D3V5, A15V5, and D2Fl. Proteins
were immunopurified using beads containing covalently linked anti-Flag
MAb (C) or anti-V5 MAb (D) and analyzed by SDS-PAGE followed by
Western blotting with antibodies to the proteins indicated on the right.detected in the total lysate of cells infected with vA15V5
was also detected in the affinity-purified complex from
these cells, whereas none of these proteins were detected in
the affinity-purified material from cells infected with control
virus (Fig. 2A). These experiments supported the existence
of a complex containing A15, F10, G7, J1, and A30.
To provide further evidence for the presence of D2 in the
complex, we made recombinant VAC vD2Fl with a Flag-tag
appended to the predicted C-terminus of the D2L ORF in
vF10V5, again without disturbing the D2 promoter and
using GFP as a reporter. Although referred to as vD2Fl, this
recombinant has a V5 tag on F10 as well as a Flag tag on
D2. Proteins from cells infected with vD2Fl or the parental
vF10V5 were immunopurified with anti-Flag antibody and
analyzed by Western blotting with specific antibodies.
F10V5, G7, J1, D2Fl, and A30 were each detected in the
affinity purified proteins from cells infected with vD2Fl but
not from the similarly purified proteins from cells infected
with control virus (Fig. 2B).
Because of overlapping ORFs and transcriptional signals,
we did not make a recombinant virus with an epitope-tagged
D3. Instead, we used a transfection expression protocol.
Cells were infected with vTF7-3, a recombinant virus that
constitutively expresses the bacteriophage T7 RNA poly-
merase (Fuerst et al., 1986), and transfected with various
combinations of plasmids containing a V5-tagged copy of
A15 (A15V5), a V5-tagged copy of D3 (D3V5), or a Flag-
tagged copy of D2 (D2Fl), each under the control of the T7
promoter. Extracts of cells that had been transfected with
plasmids expressing A15V5 and D3V5 in the presence or
absence of a plasmid expressing D2Fl were incubated with
an anti-Flag MAb conjugated to beads. The bound proteins
were analyzed by SDS-PAGE followed by Western blotting.
F10, G7, D3V5, and A15V5 were detected only when D2Fl
was expressed (Fig. 2C). Using a similar transfection
approach, J1, D2Fl, and A30 were shown to be associated
with A15V5 (Fig. 2D). Taking the experiments in this
section together, we concluded that A15, A30, D2, D3, F10,
G7, and J1 are part of a multiprotein complex, though
subcomplexes may also exist.
To further characterize the complex, we used a mixture of
[35S]methionine and [35S]cysteine to metabolically label
proteins in cells infected with vA15V5 or wild-type VAC
strain WR. Infected cell extracts were incubated with beads
covalently linked to anti-V5 MAb and the bound proteins
were analyzed by SDS-PAGE and visualized by autoradiog-
raphy. Bands specific for the extracts from cells infected with
the vA15V5, relative to the control, had apparent masses of
42, 27, 18 (doublet), 12, and 9 kDa, consistent with G7, D3,
J1 and D2, A15V5, and A30 proteins, respectively (Fig. 3).
Except for the absence of a radioactive 50-kDa band, this
pattern was similar to the Coomassie blue-stained bands
obtained by affinity purification of proteins associated with
F10V5 (Fig. 1) and no additional bands were detected. West-
ern blotting or mass spectrometry confirmed the identities of
G7, D3, J1, A15V5, and A30 (data not shown). Since the
Fig. 4. Synthesis of A15V5 and localization in virus particles. (A) Western
blot analysis. BS-C-1 cells were mock infected (M) or infected with
vA15V5 in the absence or presence of cytosine arabinoside (AraC) and
harvested at 2–24 h postinfection as indicated. Total cell lysates were
analyzed by SDS-PAGE and Western blotting with anti-V5 MAb. Masses
(kDa) of marker proteins are indicated at the left. (B) Virion fractionation.
IMVs were purified by sucrose gradient centrifugation from cells infected
with vA15V5 and incubated in buffer containing (+) or lacking () NP-40
or DTT. The mixture was centrifuged and the proteins in the pellet (P) and
supernatant (S) were analyzed by SDS-PAGE and Western blotting using
anti-V5 and anti-A14 antibodies as indicated on the right.
Fig. 3. Autoradiographs of metabolically labeled proteins that co-purified
with A15V5 or D2Fl. BS-C-1 cells were infected with vA15V5, vD2Fl, or
control VAC WR, and labeled with a [35S]methionine and [35S]cysteine
mixture from 7 to 24 h after infection. The cells were lysed and the clarified
extracts were incubated with beads containing covalently bound anti-V5 or
-FLAGMAb as indicated at the top. After washing, the proteins were eluted
with SDS sample buffer and analyzed by SDS-PAGE followed by
autoradiography. The masses (kDa) of marker proteins are indicated on
the left. Viral proteins with mobilities that correspond to bands not present
in the control gel are indicated on the right.
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blotting as the J1 protein, the lower band corresponds to the
D2 protein. Assuming a complex with a single subunit of
each protein, one would expect the autoradiographic
intensities to follow the amount of cysteine and methionine,
that is, G7 N F10 ND3 N J1 NA15, D2 NA30. Except for F10,
the results were generally in accord with this ranking. Thus,
G7, D3, and J1 were the most intense, D2 and A15 were
intermediate, and A30 was the least intense. J1 was reported
to self-interact by yeast two-hybrid analysis (McCraith et al.,
2000), and the higher intensity of J1 compared to D3 suggests
the presence of two copies. The extreme weakness of the
radioactive band corresponding to A30 was expected, since
this protein is predicted to have a single methionine at the
initial position and no cysteines. The absence of a 50-kDa
band corresponding to F10 could not be explained by a
simple deficiency of cysteines and methionine residues.
A similar experiment was carried out by infecting cells
with vD2Fl and labeling with a mixture of [35S]methionine
and [35S]cysteine. Cell extracts were incubated with beads
conjugated to an anti-Flag MAb and analyzed by SDS-
PAGE and visualized by autoradiography. The pattern was
similar to that obtained in the previous experiment with
some minor differences (Fig. 3). D2Fl was identified by
Western blotting as the upper band of the 18-kDa doublet,
consistent with the added mass of the Flag tag, and J1 was
the lower band. In addition, the 12-kDa A15V5 in the
previous experiment was replaced by a 10-kDa A15 without
the epitope tag. The A30 band, which was faint in the
previous experiment, was barely detected. Again, we did not
see a labeled F10 band. Similarly, 35S-labeled F10 was not
detected when proteins associated with A30 were analyzed(Szajner et al., 2004b). It is clear from both mass
spectrometry and Western blotting experiments that F10 is
a component of the protein complex. We are unsure of
whether the long labeling time in amino acid-deficient
medium is causing anomalous results, perhaps due to a more
rapid turnover of F10 compared to the other proteins, or
whether F10 is present in a subset of complexes.
A15 is a late protein associated with the virus core
The previously studied components of the complex,
namely A30, D2, D3, F10, and G7, are expressed late in
infection. Examination of the DNA upstream of the A15L
ORF revealed a typical TAAAT late promoter motif.
vA15V5 was used to experimentally determine the time of
A15V5 synthesis since the promoter of the A15 ORF had not
been modified. The expected band with an apparent mass of
12 kDa was detected by SDS-PAGE and Western blotting
with anti-V5 MAb at 6 h after infection and increased in
intensity during the remainder of the 24-h time course (Fig.
4A). The A15V5 protein was not detected in lysates of cells
infected in the presence of the DNA synthesis inhibitor
cytosine arabinoside (AraC) (Fig. 4A). The promoter
sequence, time of synthesis, and inhibition by AraC indicated
that a stringent late promoter regulates A15 expression.
The association of A15V5 with sucrose gradient-purified
virions was demonstrated by Western blotting. Detergent
extraction experiments were carried out to determine
whether A15V5 is located in the membrane or core fraction
of virions. Purified IMVs were treated with the nonionic
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agent and centrifuged to separate the detergent soluble
(membrane) from the insoluble (core) fractions. The
fractions were analyzed by SDS-PAGE and immunoblotting
with anti-V5 MAb. A15V5 was detected exclusively in the
detergent-insoluble fraction (Fig. 4B). As a control to
demonstrate the extractability of a membrane protein, the
blots were also probed with antibody to the A14 protein,
which was completely released into the detergent-soluble
membrane fraction (Fig. 4B). Thus A15, like A30, G7, F10,
D2, and D3, is packaged in virus cores.
Core proteins are probably incorporated into virions at
the time of IV formation. Electron microscopy was carried
out to localize A15V5 in immature and mature virus
particles. Thin sections of cells infected with vA15V5 were
incubated with anti-V5 MAb followed by protein A
conjugated to gold spheres. Although the labeling was
relatively sparse, the majority of gold particles were
associated with the electron-dense material within the IV
and with the cores of the IMV (Fig. 5). Gold particles were
not associated with viral structures in cells infected with
wild-type virus lacking a V5 epitope tag, indicating the
absence of significant background (data not shown).
Construction and characterization of recombinant viruses
that inducibly express A15
We made three recombinant viruses in which A15 was
regulated by the E. coli lac operator and bacteriophageFig. 5. Immunogold labeling of virus structures. BS-C-1 cells were infected
with vA15V5 and harvested at 20 h after infection. The cells were fixed,
frozen, sectioned, and incubated with an antiV5 MAb followed by protein
A gold. The samples were viewed by transmission electron microscopy and
representative fields containing IV (A) and IEV (B) are shown. Arrows
point to representative gold grains.T7 RNA polymerase and chose the most stringent one to
investigate the role of the protein in virus replication. In
each construct, vT7LacOI (Alexander et al., 1992), which
contains an inducible copy of the T7 RNA polymerase
and constitutively expresses E. coli lac repressor in the
thymidine kinase locus, was used as the starting virus.
Two steps were required to make vA15V5i, as described
for the construction of other inducible viruses (Szajner et
al., 2001b). First, a C-terminal V5-tagged copy of A15,
regulated by a T7 promoter, E. coli lac operator, and the
untranslated leader sequence of encephalomyocarditis
virus RNA, was inserted into the hemagglutinin locus
of vT7LacOI. Next, the endogenous A15 gene was
deleted by homologous recombination using a plasmid
encoding GFP under the control of a VAC late promoter.
The recombinant virus v15V5i was isolated in the
presence of IPTG and plaques were identified by the
expression of GFP. We found, however, that small
plaques formed in the absence of IPTG, indicating that
either A15 was not absolutely required for virus
replication or that expression of A15 was not stringently
repressed in this construct. Thinking that the latter was
more likely, we made two additional IPTG-inducible
mutants that each had a V5 epitope-tagged copy of A15
under the control of the T7 promoter and lac operator,
without the encephalomyocarditis leader, inserted directly
into the endogenous A15L locus of vT7LacOI. In
vA15V5Li, the IPTG-inducible A15V5 gene was in the
original direction of the A15L ORF, while in the
vA15V5Ri virus, the inducible gene was inserted in the
reverse orientation (Fig. 6A). The gene encoding GFP,
under the control of a VAC late promoter, was co-inserted
to allow selection of the recombinant virus. Plaque
formation was completely inhibited in the absence of
IPTG in cells infected with vA15V5Ri (Fig. 6B), whereas
small plaques formed with vA15V5Li (data not shown),
suggesting that expression of A15V5 was more efficiently
repressed in vA15V5Ri. We attribute the less stringent
control in vA15V5Li to RNA originating from A16L and
reading though the lac operator sequence. Presumably this
read-through RNA can be inefficiently translated to pro-
duce low levels of A15V5, although this was not directly
examined. In vA15V5Ri, the RNA originating from A16L
is complementary to the A15V5 transcripts, which may
partially suppress A15V5 expression as seen by the small
plaque size relative to the parent virus vT7lacOI or
vA15V5 even in the presence of IPTG (Fig. 6B). The
overlap of A15V5 transcripts with A16L transcripts could
also contribute to the slightly reduced plaque size in the
presence of IPTG.
The inability of vA15V5Ri to form plaques in the
absence of IPTG could be due to a reduction in virus spread
or replication. To discriminate between these possibilities,
we analyzed virus yields under one-step growth conditions.
Initial experiments indicated that the yield of virus was
proportionate to IPTG concentration, reaching a maximum
Fig. 7. Physical and functional dependence of F10 on A15V5 expression.
Cells were infected with vA15V5Ri in the presence of indicated amounts of
IPTG. After 24 h, cell lysates were examined by Western blotting with
antibodies to V5, F10, tyrosine phosphates (PY), and threonine phosphates
(PT).
Fig. 6. Construction and characterization of vA15V5 inducible mutants.
(A) Diagrams of portions of the VAC WR, vA15V5, vA15V5Ri, and
vA15V5Li genomes. Abbreviation: GFP, enhanced green fluorescent
protein; PT7O, bacteriophage T7 promoter regulated by the lac
operator. (B) Virus plaques. BS-C-1 monolayers were infected with
vT7lacOI, vA15V5Ri, or vA15V5, and covered with a methylcellulose
overlay. After 48 h, the overlay was removed and the plates were
stained with crystal violet. (C) Time course of vA15V5Ri reproduction.
BS-C-1 cells were infected with 5 PFU per cell of vT7lacOI (n) or
vA15V5Ri in the presence ( S ) or absence (w) of 50 AM IPTG. Virus
yields were determined at various times by plaque assay in the
presence of IPTG.
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yield of vA15V5Ri was about 2 logs lower than the parental
vT7lacOI. Even with an optimal concentration of IPTG,
however, the kinetics of vA15V5Ri replication was retarded
compared to vT7LacOI (Fig. 6C), consistent with the
smaller plaque size.Functional interaction between A15 and F10 kinase
Lysates of vA15V5Ri-infected cells were analyzed by
SDS-PAGE followed by Western blotting using an anti-V5
MAb to correlate levels of A15V5 protein with virus
replication. In the absence of IPTG, the A15V5 band was
not seen even after 24 h (Fig. 7). The band was barely
detectable at 5 and 10 AM IPTG, and was maximally
induced at 50 AM. A time course experiment indicated that
the onset of A15V5 synthesis under the inducible T7
promoter was slightly retarded relative to that of the natural
promoter (data not shown). This delay could contribute to
the lag in virus replication and the small plaque size.
In a previous study, we showed that the A17
membrane protein was stable in the absence of A30 or
G7 expression but that phosphorylation of tyrosine and
threonine residues was reduced, and that this effect was
correlated with a decrease in the stability of the F10
protein kinase. To determine whether inhibition of A15
had similar effects on F10 and the phosphorylation of
A17, lysates of cells infected with vA15V5Ri in the
presence of increasing concentrations of IPTG were
analyzed by SDS-PAGE followed by Western blotting
with antibodies that recognize F10 and phosphorylated
tyrosine and threonine in A17. The level of F10 and the
tyrosine phosphorylation of A17 paralleled the induction
of A15V5, suggesting that the kinase is unstable in the
absence of A15 (Fig. 7).
Processing of viral core proteins and association of viral
membranes and viroplasm are inhibited in the absence of
A15V5 expression
Maturation of IV into IMV is coupled to the proteolytic
cleavage of the viral precursor proteins P4a, P4b, and 28 K
to generate the major core proteins 4a, 4b, and 25 K (Katz
and Moss, 1970). Consequently, cleavage is inhibited when
either A30 or G7 is repressed (Szajner et al., 2001b, 2003).
To investigate the effect of inhibition of A15 expression on
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pulse-chase experiments. Cells were infected with either
vA15V5Ri in the presence or absence of IPTG. As a
control, cells were infected with vT7LacOI in the presence
or absence of rifampin, which blocks morphogenesis and
proteolytic processing (Katz and Moss, 1970; Moss et al.,
1969; Nagayama et al., 1970). Pulse labeling indicated that
the core protein precursors P4a, P4b, and 28K were
synthesized at similar levels in cells infected with different
viruses under permissive or nonpermissive conditions (Fig.
8). However, proteolytic processing of P4a and 28K to the
core proteins 4a and 25K was severely inhibited in the
absence of A15 expression while cleavage of P4b was
incompletely blocked (Fig. 8).
Electron microscopy was used to determine the effect of
inhibition of A15 expression on the morphogenesis of VAC.
Cells infected in the presence of IPTG contained large
numbers of immature (Fig. 9B) and mature (not shown)
virions, which were indistinguishable from those observed
in cells infected with wild-type virus. In contrast, no mature
virions were found in cells infected with vA15V5Ri in the
absence of the inducer. Instead, there were large masses of
dense viroplasm and most of the circular IV did not enclose
electron-dense material that is normally observed in IV (Fig.
9A). Some viral membranes formed layers that closely
resembled those seen in cells infected with vA30Li or
vG7Li under nonpermissive conditions (Szajner et al.,
2001b, 2003). Only a small minority of the IV made in
the presence of IPTG appeared empty and masses of
viroplasm were not seen (Fig. 9B).Fig. 8. Effect of A15V5 expression on the processing of viral proteins.
Cells were infected with 5 PFU per cell of vA15V5Ri in the presence or
absence of IPTG or the parent virus vT7lacOI in the presence or absence
of rifampin (RIF). At 9 h after infection, the cells were pulse labeled
with [35S]methionine and cysteine for 30 min, washed, and chased for 13
h in medium containing excess unlabeled methionine and cysteine. The
proteins were analyzed by SDS-PAGE and autoradiographs are shown.
The masses in kDa are indicated on the left and the prominent precursor
proteins P4a, P4b, and 28K and their major cleavage products 4a, 4b,
and 25K, respectively, on the right.Associations of viral membranes and viroplasm are
dependent on D2 and D3
In a previous study, Dyster and Niles (1991) showed that
proteolytic cleavage of the major core precursor protein P4a
was impaired in cells infected at 40 8C with temperature-
sensitive (ts) viruses that map to the D3R or D2L ORF,
whereas processing of P4b was less affected. This is similar
to the result we found by repressing A15 synthesis. To
determine the step at which virion assembly was blocked,
BSC-1 cells were infected with ts mutants Ets52 or Cts35,
which map to D2L and D3R, respectively, at 31 or 40 8C
for 20 h and analyzed by transmission electron microscopy.
All viral structures, including crescents, IV, IMV, IEV, and
CEV were observed in cells infected with Cts35 (Fig. 10B)
or Ets52 (Fig. 10D) virus at 31 8C. In contrast, no mature
virions were seen in cells infected with either ts virus at
nonpermissive temperature. Instead, these cells showed
large areas of cytoplasm devoid of cellular organelles
(Figs. 10A and C), similar to the large cleared areas
observed in cells infected with ts viruses that map to the
F10L ORF. Some of these areas contained a small number
of crescent-shaped and circular viral membranes, the
majority of which lacked the electron-dense material that
is normally enclosed by IV (Figs. 10A and C). In addition,
large masses of electron-dense material with a lacey
appearance and clearly separated from the viral membranes
were observed (Fig. 10C).
We previously noticed that elevated temperature can
have secondary effects on morphogenesis (Szajner et al.,
2001a, 2004b), making it desirable to construct inducible
mutants of D2 and D3. The partially overlapping arrange-
ment of genes in the HindIII D fragment made it difficult to
design inducible viruses by engineering the endogenous
copies of D2 and D3 as we did with A15. We therefore
depended on a two-step procedure in which the inducible
copy is inserted in the hemagglutinin locus of vT7lacOI and
the original copy is deleted (Szajner et al., 2001b).
Recombinant VACs vD2Fli (Fig. 11A) and vD3Vgi (not
shown), containing an IPTG-inducible copy of a Flag
epitope-tagged D2 or vesicular stomatitis virus glycoprotein
epitope-tagged D3, respectively, were constructed.
Recombinant vD2Fli exhibited a severe defect in plaque
formation in the absence of IPTG (Fig. 11B), whereas
vD3Vgi was less affected (not shown) and was judged too
leaky for use. Even in the presence of IPTG, the plaques
formed by vD2Fli were small (Fig. 11B). Raising the IPTG
above 25 AM IPTG had little effect (data not shown).
Smaller than normal size plaques were also observed in cells
infected with vD2Fl (Fig. 11B), which contains a C-terminal
Flag-tagged copy of D2 under the D2 promoter, suggesting
that the tag is deleterious to optimal viral replication or
spread. Importantly, in a one-step growth experiment, the
yield of vD2Fli in the absence of IPTG was nearly 2 logs
lower than in the presence of inducer, indicating a specific
requirement for D2Fl expression (Fig. 11C).
Fig. 9. Transmission electron microscopic images of cells infected with vA15V5Ri. BS-C-1 cells were infected with vA15V5Ri in the absence (A) or presence
(B) of 50 AM IPTG. After 20 h, the cells were prepared for transmission electron microscopy. Electron micrographs are shown with the scale indicated by the
bar. Abbreviations; VP, viroplasm; IV, immature virions; n, nucleoid within an IV.
P. Szajner et al. / Virology 330 (2004) 447–459454To determine whether repression of D2 inhibited proteo-
lytic cleavage of the major core proteins, BS-C-1 cells were
infected with the vD2Fli virus in the presence or absence of
IPTG and pulse labeled with a mixture of [35S]methionine
and [35S]cysteine. As a control, cells were infected withFig. 10. Transmission electron microscopic images of cells infected with ts mutants
(D2 mutant) at 40 8C (A) or 31 8C (B) or with Cts35 (D3 mutant) at 40 8C (C)vT7LacOI in the presence or absence of rifampin. The results
were virtually identical to that shown in Fig. 8 for repres-
sion of A15V5. Inhibition of D2 expression had no effect on
the synthesis of viral late proteins but reduced the formation
of 4a and 25 K and to a lesser extent 4b (data not shown).that map to the D2L and D3R ORFs. BS-C-1 cells were infected with Ets52
or 31 8C (D). Abbreviations as in legend of Fig. 9.
Fig. 11. Construction of an inducible D2 mutant. (A) Diagram of vD2Fli. The J2R (thymidine kinase, TK), D2L, and A56R (HA) loci are shown. Insertions
into these loci are displayed below the line. Additional abbreviations: P11, VAC late promoter; P7.5, VAC early late promoter; LacO, E. coli lac operator; lacI,
E. coli lac repressor gene; T7 pol, bacteriophage T7 RNA polymerase gene; PT7, bacteriophage T7 promoter; EMC, encephalomyocarditis virus cap-
independent translation enhancer element; gfp, enhanced green fluorescent protein gene; gpt, E. coli guanine phosphoribosyltransferase gene. (B) Effect of
IPTG on plaque formation. BS-C-1 cells were infected with vT7lacOI, vD2Fli, or vD2Fl in the presence or absence of 50 AM IPTG. After 48 h, cell monolayers
were stained with crystal violet. (C) Time course of vD2Fli replication in the presence or absence of IPTG. Cells were infected with vT7lacOI ( S ) or vD2Fli in
the presence (E) or absence (D) of 50 AM IPTG. After 24 h, the cells were harvested and tittered on BS-C-1 cells in the presence of 50 AM IPTG.
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inhibition of D2 expression resulted in a block in morpho-
genesis similar to the one observed in cells infected at the
nonpermissive temperature with ts mutants. In these experi-
ments, BSC-1 cells infected with vD2Fli at 37 8C in the
presence or absence of IPTG were fixed at 20 h after
infection and prepared for transmission electron microscopy.
All forms of VAC, including crescents, IV, IMV, IEV, EEV,
and CEV were readily found in cells infected with vD2Fli in
the presence of IPTG (Fig. 12B and data not shown). In
contrast, the cytoplasm of cells infected in the absence of the
inducer showed no mature virions. Instead, these cells con-
tained large masses of electron-dense viroplasm separatedfrom large numbers of crescent-shaped and bemptyQ circular
viral membranes (Fig. 12A). These structures are strikingly
similar to those observed in cells infected with the inducible
A30 (Szajner et al., 2001b), G7 (Szajner et al., 2003), J1
(Chiu and Chang, 2002), and A15 (this paper) mutants.Discussion
The assembly of VAC virions involves interacting protein
complexes. There is indirect evidence for a complex
comprised of at least six proteins involved in transcription
and mRNA processing that is targeted to virus cores by
Fig. 12. Transmission electron microscopy of cells infected with vD2Fli in the absence (A) or presence (B) of IPTG. Procedures and abbreviations as in the
legend of Fig. 9.
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1994). In addition, there are numerous examples of pair-wise
protein interactions. Here we describe a complex comprised
of seven proteins that are involved in an early stage of
morphogenesis. The F10 protein kinase was selected as the
target for our study because of previous evidence that it is
required for assembly of viral membranes (Traktman et al.,
1995; Wang and Shuman, 1995) and interacts with two
proteins, A30 and G7, which are required for association of
viral membranes with viroplasm (Szajner et al., 2001b, 2003,
2004b). To isolate the putative complex, we infected cells
with a recombinant VAC in which the F10 protein had a short
C-terminal epitope-tag. As a control, cells were infected with
wild-type VAC lacking the tag. By subjecting the extracts
from both infections to an identical immunoaffinity purifi-
cation procedure with a MAb to the epitope tag, we
distinguished specific and nonspecific binding proteins.
The specific bands were excised from a denaturing gel and
tryptic peptides from seven viral proteins, namely A15, A30,
D2, D3, F10, G7, and J1, were identified by liquid
chromatography and mass spectroscopy. At this stage, we
could not be sure whether the isolated proteins interacted
individually or as part of a large complex with F10. Evidence
for the latter was obtained by epitope tagging A15, D2, and
D3 separately and in each case affinity purifying the same set
of proteins. We suspect that there is little free F10, A30, or
G7 because these proteins are unstable in the absence of
other components of the complex. It will surely be
interesting to determine the mechanism of degradation of
the uncomplexed proteins. In this context, Dyster and Niles
(1991) found that a ts mutation of D2 rendered both D2 and
D3 unstable and that a ts mutation of D3 rendered both
proteins unstable. Except for F10 and J1, the polypeptides
comprising the complex appeared to be present in equimolar
ratios. F10 appears to be present in only a subset of
complexes and J1 might be present as a homodimer.
A high-throughput yeast two-hybrid analysis revealed 37
VAC protein interactions, but the only one relevant to thepresent study was the interaction of J1 with itself (McCraith
et al., 2000). Nevertheless, this system might identify
additional interactions if protein fragments of specific
proteins were used. Another approach, consisting of the
expression pairs of proteins in a cell-free system, suggested
an interaction of D2 and D3 and of D2 and A15 (P.S.,
unpublished observation).
The seven proteins forming the complex are conserved in
all chordopoxviruses, implying a common function in each.
However, none of the proteins except for F10 have any
recognizable motifs, pointing to purely structural roles.
Indeed, repression of A30, G7, J1, A15, or D2 gives the
same phenotype: the failure of viral membranes and
viroplasm to associate with each other. Present and previous
studies have shown that A15, A30, D2, D3, F10, and G7 are
localized in virus cores (Dyster and Niles, 1991; Szajner et
al., 2001b, 2003, 2004b). Although J1 was reported to be a
membrane protein (Chiu and Chang, 2002), we found it to
be associated with viroplasm and cores (P.S and A.S.W.,
unpublished). Nevertheless, it seems likely that the protein
complex interacts with some membrane protein(s) to
accomplish its role in morphogenesis. The A17 and A14
membrane proteins are good candidates, as they are
phosphorylated by the F10 protein kinase (Betakova et al.,
1999; Derrien et al., 1999; Mercer and Traktman, 2003;
Traktman et al., 2000). The interaction between the complex
and membrane proteins may not withstand the conditions of
cell lysis and immunopurification, making alternative
methods of investigation necessary.Materials and methods
Cell and viruses
BS-C-1 (ATCC CCL6) and HeLa S3 (ATCC CCL2.2)
cells were grown in Eagle’s minimal essential medium (E-
MEM) and Dulbecco’s modified Eagle’s medium (D-MEM),
P. Szajner et al. / Virology 330 (2004) 447–459 457respectively, each obtained from Quality Biologicals Inc and
supplemented with 10% fetal bovine serum (FBS). Wild-
type and recombinant VACs were propagated in HeLa cells
as previously described (Earl et al., 1998a). Conditional
lethal inducible viruses were propagated in the presence of
50 AM isopropyl-h-d-thiogalactopyranoside (IPTG) and
2.5% FBS. All virus stocks were stored at 70 8C.
Construction of recombinant viruses
Standard procedures were used for construction and
isolation of recombinant viruses (Earl et al., 1998b) with
modifications (Szajner et al., 2004b). Plaques containing
recombinant VACs expressing GFP were picked using an
inverted fluorescence microscope and clonally purified by
repeated plaque isolations. Inserted genes were analyzed by
PCR and DNA sequencing.
Plaque assay
BS-C-1 cell monolayers, in 6-well tissue culture plates,
were infected with 10-fold serial dilutions of virus. After 1 h
of adsorption, inocula were removed and replaced with
complete E-MEM containing 2.5% FBS, 0.5% methylcel-
lulose, with or without 50 AM IPTG. The infected cells were
incubated at 37 8C for 2 days, stained with crystal violet,
and the plaques counted (Earl et al., 1998b).
One-step virus growth
BS-C-1 cell monolayers, in 6-well tissue culture plates,
were infected with 5 PFU of VAC per cell. After 1 h, inocula
were removed and cell monolayers were washed twice with
E-MEM containing 2.5% FBS. The cells were then
incubated in E-MEM containing 2.5% FBS with or without
50 AM IPTG and harvested at various times after infection.
The infected cells were subjected to three freeze/thaw
cycles, sonicated, and stored at 70 8C. Virus titers were
determined by plaque assay in the presence of 50 AM IPTG.
Antibodies
The murine MAb anti-V5 (Invitrogen, Carlsbad, CA) re-
cognizes the 14-amino acid sequence GKPIPNPLLGLDST
found in the P and V proteins of the paramyxovirus SV5.
The murine MAb anti-FLAG M2 (Sigma-Aldrich, St Louis,
MO) recognizes the 9-amino acid sequence DYKDDDDK.
Rabbit polyclonal anti-phosphotyrosine (anti-pTyr) and anti-
phosphothreonine (anti-pThr) antiserum was purchased
from Zymed Laboratories (South San Francisco, CA).
Affinity purification and mass spectroscopy of protein
complexes
Three roller bottles containing 4.5  108 BS-C-1 cells
were infected with vF10V5 at a multiplicity of 3 PFU percell for 2 h and incubated at 37 8C. At 48 h after
infection, the cells were harvested, washed with cold Tris-
buffered saline, and lysed in the presence of protease
inhibitor cocktail tablets for 30 min on ice. The cell lysate
was clarified by centrifugation at 20,000  g for 30 min
at 4 8C and the supernatant was rotated with 1 ml of 50%
vol/vol slurry of the anti-V5 affinity matrix for 4 h. The
beads were washed five times with 10 ml of lysis buffer.
The proteins were eluted by washing the beads two times
with 0.5 ml of 100 mM glycine pH 2.0. The eluted
proteins were precipitated with 20% trichloroacetic acid,
resuspended in 1 M Tris pH 9.0 plus 2 sample buffer
and analyzed by SDS-PAGE, and visualized by Coomassie
blue staining. Coomassie blue-stained bands were excised
and subjected to in-gel tryptic digestion (Moritz et al.,
1995). The resulting digests were concentrated and
analyzed by capillary high pressure liquid chromatography
coupled to a Model LCQ ion trap mass spectrometer
(ThermoFinnigan, San Jose, CA) equipped with an
electrospray interface as described (Szajner et al., 2003).
Uninterpreted MS/MS spectra were searched against the
NR database utilizing BioWorks and SEQUEST software
(ThermoFinnigan).
Western blot analysis
Proteins from infected cell lysates or purified virions
were resolved by SDS- PAGE and electrophoretically
transferred to a nitrocellulose membrane (Osmonics, Inc).
Membrane blocking, antibody binding, and chemilumines-
cent detection were carried out as previously described
(Szajner et al., 2004b).
Virion fractionation
Purified virus particles (108 PFU) were incubated in a
reaction mixture containing 50 mM Tris–HCl pH 7.5, 1%
(vol/vol) NP40, with or without 50 mM dithiothreitol for
1 h at 37 8C. Insoluble and soluble materials were
separated by centrifugation at 20,000  g for 30 min at
4 8C.
Electron microscopy
Infected cells were fixed in 2% glutaraldehyde in 0.1
M sodium cacodylate buffer, washed in 0.1 M sodium
cacodylate buffer, post-fixed with reduced osmium
tetroxide, and washed in buffer. Cells were dehydrated
in a series of ethyl alcohol dilutions (50%, 70%, and
100%) followed by incubation in propylene oxide. The
cells were then embedded in EMbed 812. Sections were
obtained using the Leica Ultracut S ultramicrotome.
Thin sections were stained with 7% uranyl acetate in
50% ethanol and then with 0.01% lead citrate and
analyzed on the Philips CM100 transmission electron
microscope.
P. Szajner et al. / Virology 330 (2004) 447–459458Analysis of metabolically labeled polypeptides by
SDS-PAGE
BS-C-1 cells were infected with 10 PFU of virus per cell
and incubated for 1 h at 37 8C. The inocula were removed
and the infected cells were incubated with E-MEM
containing 2.5% FBS, with or without of 50 AM IPTG or
with or without 100 Ag/ml of rifampin. At 9 h after
infection, pulse labeling was carried out with 100 ACi/ml of
[35S]methionine and [35S]cysteine for 30 min in methionine-
and cysteine-free medium containing 2.5% dialyzed FBS.
The cells were harvested, washed once with cold phosphate-
buffered saline, and incubated with 0.01 Ag/Al of micro-
coccal nuclease in 10 mM Tris–HCl pH 7.5, 10 mM KCl, 1
mM CaCl2, 0.2% (vol/vol) NP-40, 20 mM h-mercaptoe-
thanol, and 0.2 mM phenylmethylsulfonyl fluoride for 30
min on ice. For pulse chase experiments, the labeling
medium was removed and replaced with E-MEM containing
2.5% FBS and incubated for 15 h prior to lysis. The samples
were analyzed by SDS-PAGE as previously described
(Szajner et al., 2004b).Acknowledgments
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